Sex | Age | Graft | Priming | Conditioning | Purge | Disease pattern | Organ involvement | Survival (days) | Cause of death | |||||||||
Procedure related deaths | ||||||||||||||||||
M | 33.6 | NT3-150 | Cy 3-150+ G-CSF3-150 | None | None | Diffuse | L3-150, O3-150 | 0 | Sudden cardiac death, coronary atherosclerosis at necropsy | |||||||||
F | 50.1 | NT | Cy +G-CSF | None | None | Limited | L, PAH3-150 | 0 | Neutropenic fever, pneumonia, cardiac failure | |||||||||
F | 38.0 | NT | Cy +G-CSF | None | None | Diffuse | L, O | 0 | Thrombocytopenia, pulmonary haemorrhage, myocarditis? | |||||||||
F | 18.9 | ASCT3-150 | G-CSF | Cy +ATG3-150 | None | Diffuse | L | 11 | Diffuse alveolar haemorrhage | |||||||||
F | 41.0 | ASCT | G-CSF | Cy +ATG + TBI3-150 | CD34 | Diffuse | L, O | 28 | Interstitial pneumonitis | |||||||||
M | 47.2 | ASCT | Cy +G-CSF | Cy | NA3-150 | Diffuse | L, GI3-150, R3-150 | 40 | Central nervous system bleed | |||||||||
F | 57.3 | ASCT | G-CSF | Cy +ATG + TBI | CD34 | Diffuse | L, GI | 79 | Interstitial pneumonitis | |||||||||
Disease related deaths | ||||||||||||||||||
M | 45.1 | NT | Cy +G-CSF | None | None | Diffuse | L, O, PAH | 0 | Disease progression | |||||||||
F | 54.1 | ASCT | Cy +G-CSF | BCNU3-150, thiotepa, fludarabine | CD34 | Diffuse | L, O, PAH | 217 | Pulmonary hypertension | |||||||||
F | 38.1 | ASCT | Cy +G-CSF | Cy | CD34 + CAMPATH | Diffuse | L, O | 242 | Disease progression | |||||||||
F | 42.0 | ASCT | Cy +G-CSF | Cy | CD34 + CAMPATH | Diffuse | A3-150 | 527 | Superior vena cava obstruction | |||||||||
Disease progression |
↵3-150 NT = not transplanted; ASCT = autologous stem cell transplant; Cy = cyclophosphamide; G-CSF = granulocyte colony stimulating factor; ATG = anti-thymocyte globulin; TBI = total body irradiation; BCNU = 1,3-bis(2-chloroethyl)-1-nitrosourea (carmustine); NA = data not available. Organ involvement: L = lung; O = oesophageal; PAH = pulmonary hypertension; GI = gastrointestinal; R = renal; A = arthropathy.